MedTrace Logo

A Performance Study Comparing the EyeMirage (Test Device) to Standard of Care (Reference Device) in Patients 18 to 65 Years of Age Undergoing Standard Eye Examinations Such as Visual Acuity, Visual Field, Color Vision, and Self-Paced Saccade for Various Conditions

NCT06908967 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-03-12

No results posted yet for this study

Summary

This study will assess the effectiveness and accuracy of results of a new device for eye function testing. This will be done by comparing results of four eye tests that are done through the current standard used in eye clinics and that of this new device. Participants of this study will undergo the four eye tests using both the new device and the standard of care devices.

The study will be done in one visit to the eye clinic. Thirty days after the eye tests were done, participants will be called by the clinic for a general follow-up and to discuss any problems, if needed.

Conditions

  • Visual Function

Interventions

DEVICE

EyeMirage device

This is a novel, smartphone-based device powered by artificial intelligence that will be used for virtual and remote routine eye examinations.

Sponsors & Collaborators

  • St. Boniface Hospital

    collaborator OTHER

  • St. Boniface Hospital Asper Clinical Research Institute

    collaborator UNKNOWN

  • Neuroptek Corporation Inc.

    lead OTHER

Principal Investigators

  • Bram Ramjiawan, PhD · St. Boniface Hospital Asper Clinical Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-13
Primary Completion
2026-02-24
Completion
2026-02-24

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06908967 on ClinicalTrials.gov